Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval

A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.

The US Food and Drug Administration (FDA) has granted key approval for a drug that could extend the lives of large and giant-breed dogs. The drug, LOY-001, is being developed by Loyal, a biotechnology company based in San Francisco. The FDA has approved the Reasonable Expectation of Effectiveness section of Loyal's application for conditional approval. This means that the FDA believes that LOY-001 is likely to be effective in extending the lifespan of large and giant-breed dogs.

According to a letter disclosed by Loyal to the New York Times, a representative from the US Food and Drug Administration stated, "The data you provided are sufficient to show that there is a reasonable expectation of effectiveness."

On average, larger dogs generally have a lifespan of approximately 8 to 12 years, according to information from the American Kennel Club. Specifically, Bernese Mountain Dogs have a life expectancy of 7-10 years, while Great Danes typically live around 8-10 years.